XML 57 R36.htm IDEA: XBRL DOCUMENT v2.4.0.8
Selected Quarterly Financial Data (Unaudited) (Tables)
12 Months Ended
Dec. 31, 2013
Quarterly Financial Information Disclosure [Abstract]  
Summary of Selected Quarterly Financial Data
    2013  
    Q1     Q2     Q3     Q4  
    (In thousands, except per share data)  

Net patient revenues from continuing operations

  $ 61,432      $ 65,227      $ 64,368      $ 67,256   

Net revenues from continuing operations

  $ 62,756      $ 66,868      $ 65,829      $ 68,605   

Operating income from continuing operations

  $ 8,435      $ 11,059      $ 9,904      $ 9,372   

Net income from continuing operations including noncontrolling interests

  $ 5,809      $ 7,642      $ 6,756      $ 5,796   

Net income from continuing operations attributable to common shareholders

  $ 3,851      $ 5,079      $ 4,659      $ 3,903   

Net losses from discontinued operations attributable to common shareholders

  $ (130   $ (165   $ (4,432   $ (42

Net income attributable to common shareholders.

  $ 3,721      $ 4,914      $ 227      $ 3,861   

Basic earnings per share attributable to common shareholders:

       

From continuing operations.

  $ 0.32      $ 0.42      $ 0.38      $ 0.32   

From discontinued operations

    (0.01     (0.01     (0.36     —     
 

 

 

   

 

 

   

 

 

   

 

 

 

Basic

  $ 0.31      $ 0.41      $ 0.02      $ 0.32   
 

 

 

   

 

 

   

 

 

   

 

 

 

Diluted earnings per share attributable to common shareholders:

       

From continuing operations.

  $ 0.32      $ 0.42      $ 0.38      $ 0.32   

From discontinued operations

    (0.01     (0.01     (0.36     —     
 

 

 

   

 

 

   

 

 

   

 

 

 

Diluted

  $ 0.31      $ 0.41      $ 0.02      $ 0.32   
 

 

 

   

 

 

   

 

 

   

 

 

 

Shares used in computation:

       

Basic.

    11,955        12,089        12,106        12,103   

Diluted

    11,979        12,110        12,120        12,117   

 

    2012  
    Q1     Q2     Q3     Q4  
    (In thousands, except per share data)  

Net patient revenues from continuing operations

  $ 60,366      $ 61,963      $ 60,719      $ 61,052   

Net revenues from continuing operations

  $ 61,771      $ 63,397      $ 62,102      $ 62,381   

Operating income from continuing operations

  $ 9,765      $ 10,806      $ 9,534      $ 8,301   

Net income from continuing operations including noncontrolling interests

  $ 6,733      $ 7,452      $ 6,423      $ 6,032   

Net income from continuing operations attributable to common shareholders

  $ 4,436      $ 4,958      $ 4,588      $ 4,230   

Net income (losses) from discontinued operations attributable to common shareholders

  $ 42      $ (109   $ (25   $ (187

Net income attributable to common shareholders

  $ 4,478      $ 4,849      $ 4,563      $ 4,043   

Basic earnings per share attributable to common shareholders:

       

From continuing operations.

  $ 0.37      $ 0.41      $ 0.39      $ 0.35   

From discontinued operations

    —          (0.01     —          (0.02
 

 

 

   

 

 

   

 

 

   

 

 

 

Basic

  $ 0.37      $ 0.40      $ 0.39      $ 0.33   
 

 

 

   

 

 

   

 

 

   

 

 

 

Diluted earnings per share attributable to common shareholders:

       

From continuing operations.

  $ 0.37      $ 0.41      $ 0.38      $ 0.35   

From discontinued operations

    —          (0.01     —          (0.02
 

 

 

   

 

 

   

 

 

   

 

 

 

Diluted.

  $ 0.37      $ 0.40      $ 0.38      $ 0.33   
 

 

 

   

 

 

   

 

 

   

 

 

 

Shares used in computation:

       

Basic

    11,955        12,089        12,106        12,103   

Diluted.

    11,979        12,110        12,120        12,117